Stacie Ropka Image

Stacie Ropka


Axinn, Veltrop & Harkrider

Stacie Ropka, PhD is a partner at Axinn, Veltrop & Harkrider LLP. Stacie’s practice focuses on intellectual property litigation, due diligence and client counseling, with an emphasis on the life sciences. Her IP counseling and due diligence experience includes extensive counseling for product development efforts relating to biologics and reconstructive biomaterials, including products that utilize adult stem cells. In addition, Stacie has served on the trial team for several patent lawsuits involving major pharmaceutical companies.

Prior to attending law school, Stacie held a faculty position at SUNY Upstate Medical University. She also spent many years as a research scientist in the fields of neurology, virology and immunology, both at Northwestern University and SUNY Upstate Medical University, and has presented her original research at numerous scientific conferences.

Recent Articles by Stacie Ropka

The CRISPR Tug of War

The University of California (“UC”) and The Broad Institute, Inc. (“Broad”) are among the leaders in the development of CRISPR technology.  Both UC and Broad filed patent applications for claims broadly drawn to CRISPR-Cas9 systems and methods of DNA editing.  These parties are currently engaged in litigation over patents concerning the potentially most lucrative application of CRISPR technology – the use of CRISPR-Cas9 in plant and animal (eukaryotic) cells.  The outcome of this litigation will affect control of the CRISPR platform and development of the technology.